Teladoc Health, Inc. (TDOC) Earnings
Teladoc Health, Inc. is expected to report next earnings on July 29, 2026 (in NaN days), with a consensus EPS estimate of $-0.24. TDOC has beaten EPS estimates in 9 of its last 12 reported quarters (average surprise +20.3% over the last four).
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Apr 29, 2026 | $-0.34 | $-0.36 | -5.5% | $614M | +0.5% |
| Feb 25, 2026 | $-0.19 | $-0.14 | +24.9% | $642M | +2.4% |
| Oct 29, 2025 | $-0.26 | $-0.21 | +19.2% | $626M | -1.4% |
| Apr 30, 2025 | $-0.33 | $-0.19 | +42.4% | $629M | +1.6% |
| Feb 26, 2025 | $-0.21 | $-0.28 | -33.3% | $640M | +0.2% |
| Oct 30, 2024 | $-0.29 | $-0.19 | +34.5% | $641M | +0.0% |
| Jul 31, 2024 | $-0.36 | $-0.28 | +22.2% | $642M | -1.1% |
| Apr 25, 2024 | $-0.47 | $-0.49 | -4.3% | $646M | +1.4% |
| Feb 20, 2024 | $-0.22 | $-0.17 | +22.7% | $661M | -1.6% |
| Jul 25, 2023 | $-0.44 | $-0.40 | +9.1% | $652M | +0.5% |
| Feb 22, 2023 | $-0.27 | $-0.23 | +14.8% | $638M | +0.7% |
| Oct 26, 2022 | $-0.59 | $-0.45 | +23.7% | $611M | +0.4% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.
Earnings call summary
Q1 FY2026 · April 29, 2026
AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.
Management highlights
• Market environment in US integrated care segment has evolved, with shift from subscription-based to visit-based arrangements. • Enhanced flagship 24-7 care offering, and advancements in AI with new data infrastructure and Prism care delivery platform. • BetterHelp's insurance rollout progressing well, live in 30 states, 6,000 providers credentialed, 150M+ insurance contracted lives. • Operational excellence focus, using AI to reduce administrative burden in BetterHelp. • Strategic priorities include building stronger business, addressing convertible notes, and capital allocation.
Guidance
2026 consolidated revenue $2.48B - $2.58B, adjusted EBITDA $267M - $306M, free cash flow $130M - $170M. Second quarter consolidated revenue $597M - $626M, adjusted EBITDA $55M - $67M. Integrated care full year adjusted EBITDA margin 15.1% - 16.1%. BetterHelp 2026 revenue guidance range down 6.5% - down 1.0%, insurance revenue $90M - $105M; second quarter BetterHelp revenue down 11.75% - down 5.25%, insurance revenue $18M - $22M
Segment performance
Consolidated revenue was $614 million. Integrated care segment: Q1 revenue $395 million, up 1.5% y/y, upper end of guidance range; adjusted EBITDA $56 million, up 12% y/y, 14.2% margin. BetterHelp: Q1 revenue $218 million, 9% lower y/y; insurance-based revenue $13 million, up $6 million q/q, high end of expectations; adjusted EBITDA $2 million, 0.9% margin
Analyst Q&A
Q: David Roman with Goldman Sachs asked about integrated care return to growth and BetterHelp growth trajectory.
A: Chuck and Mike responded on integrated care mix shift, product innovation, and BetterHelp insurance rollout progress and market stabilization.
Q: Sarah James with Cantor Fitzgerald asked about ACA subsidy-related disenrollment and visit utilization.
A: Chuck responded on ACA market evolution and mix shift impact.
Q: Daniel Grossleit with Citi asked about Better Health Insurance rollout drivers and DTC business retention.
A: Chuck responded on BetterHelp insurance execution, therapist capacity, and DTC business stance.
Q: Jalinder Singh with Truist Securities asked about chronic care business selling season and RFP trends.
A: Chuck responded on chronic care selling season, strategic conversations, and product innovation.
Q: Jessica Tasson with Piper Sandler asked about chronic care product innovation and GLP-1.
A: Chuck responded on chronic care innovation and GLP-1 market stance.
Q: Sean Dodge with BMO Capital Markets asked about integrated care revenue initiatives.
A: Chuck responded on integrated care product innovation and activation points.
Q: Charles Rhee with TD Cowan asked about BetterHelp cannibalization and revenue lift.
A: Chuck responded on BetterHelp insurance revenue lift and cannibalization.
Q: Brian Ten Quillett with Jefferies asked about Better Health therapist capacity and adoption.
A: Chuck responded on BetterHelp therapist capacity and progress.
Q: Alan Lutz with Bank of America asked about BetterHelp average copay and 800 bps revenue lift.
A: Chuck responded on BetterHelp copay and 800 bps revenue lift explanation.
Q: Elizabeth Anderson with Evercore ISI asked about BetterHelp state rollout pace.
A: Chuck responded on BetterHelp state rollout progress and gating factors.
Q: George Hill with Deutsche Bank asked about BetterHelp margin expansion.
A: Chuck responded on BetterHelp margin expansion and opportunity.
Q: Michael Charney with Lerink Partners asked about BetterHelp 800 bps growth differential.
A: Chuck responded on BetterHelp growth differential and revenue growth drivers.
Q: Scott Schoenhass with KeyBank asked about chronic care product cycle and margin.
A: Chuck responded on chronic care product innovation and margin leverage.
Q: Peter Warndorf with Barclays asked about integrated care membership and CFO search.
A: Chuck responded on integrated care membership and CFO search.
Q: Jeff Garrow with Stevens asked about BetterHelp gross margins and ad spend efficiency.
A: Chuck responded on BetterHelp gross margins and ad spend efficiency.
Q: Ryan McDonnell with Needham asked about integrated care implementation delays and visit-based contracts.
A: Chuck responded on integrated care implementation delays and visit-based contracts visibility